The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study
Sponsor: Sindh Institute of Urology and Transplantation
This observational or N/A phase trial investigates Breast Cancer and Breast Cancer Invasive and is currently completed. Sindh Institute of Urology and Transplantation leads this study, which shows 3 recorded versions since 2022 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2022 — Jul 2024 [monthly]
Completed
First recorded
Feb 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sindh Institute of Urology and Transplantation
For direct contact, visit the study record on ClinicalTrials.gov .